Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-24

FDA Approved: LEFLUNOMIDE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a generic Leflunomide tablet from Zydus Lifesciences Limited under an Original Application (ANDA212308).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

ORIG AP for LEFLUNOMIDE (LEFLUNOMIDE)